- Home
- /
- High Courts
- /
- Delhi High Court
- /
- Patent Infringement: Delhi High...
Patent Infringement: Delhi High Court Restrains Zydus From Manufacturing Biologic Similar To 'Nivolumab' Cancer Drug
Nupur Thapliyal
19 July 2025 10:00 PM IST
The Delhi High Court has restrained Zydus Lifesciences Limited from manufacturing, selling importing, exporting or dealing in any biologic which is similar to Nivolumab, a drug used to treat cancer, sold under the brand name “Opdivo.”Justice Mini Pushkarna passed the interim order in favour of Nivolumab's manufacturer company- E.R. Squibb and Sons LLC, in its patent infringement suit...
This is a premium content
Available exclusively to
Our subscribers
Subscribe Premium
INR 1099+GST
Your support helps us to bring you more content at
an affordable subscription scheme !!!
All payment options available
Tags
Nupur Thapliyal
Nupur Thapliyal is a Principal Correspondent with LiveLaw, based in New Delhi. She reports from the Delhi High Court and trial courts in the national capital
Next Story



